Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion type Assertion NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_head.
- NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion description "[To determine immunodominant PLP epitopes, proliferative responses of 971 PLP-specific lines were tested with 27 overlapping 20-amino acid peptides encompassing the human PLP sequence and the binding affinities of the PLP peptides to DRB5*0101 and DRB1*1501, DR2 MHC class II isotypes associated with multiple sclerosis, were determined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_provenance.
- NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion evidence source_evidence_literature NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_provenance.
- NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion SIO_000772 7541828 NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_provenance.
- NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion wasDerivedFrom befree-20140225 NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_provenance.
- NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_assertion wasGeneratedBy ECO_0000203 NP427485.RAb6lBsk_C21cT6RnEOzvSFG32IU3U-wDA1NiDmI_r6bg130_provenance.